What it is: A naturally occurring copper tripeptide found in human plasma, saliva, and urine that declines significantly with age, studied for tissue regeneration and anti-aging effects.
Research suggests: Research shows GHK-Cu can activate over 4,000 genes related to tissue remodeling, anti-inflammation, and repair, with both injectable and topical forms studied.
Best for: Skin regeneration and longevity researchers
Key thing to know: Naturally present in human plasma; levels drop from roughly 200 ng/mL at age 20 to below 80 ng/mL by age 60, making it a genuine age-related decline marker.
What is GHK-Cu?
GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper) is a naturally occurring tripeptide first isolated from human plasma in 1973 by Loren Pickart. It pairs the sequence Gly-His-Lys with a copper(II) ion integral to its activity. Plasma levels decline with age — from roughly 200 ng/mL at 20 to below 80 ng/mL by 60.
This age-related decline has made GHK-Cu a subject of considerable interest in longevity and regenerative medicine research.
GHK-Cu is best known in its topical form, widely used in skincare for collagen synthesis and skin remodeling. But the research extends beyond cosmetics: Pickart's work and later studies identify GHK-Cu as a tissue-repair signal that modulates hundreds of genes involved in inflammation, antioxidant defense, DNA repair, and regeneration — drawing substantial interest in anti-aging and wound-healing research.
How GHK-Cu Works
In research, the proposed mechanism has several parts.
Tissue repair signal: GHK-Cu's primary mechanism is as a tissue-repair signal. At sites of damage, it is released from breakdown of the protein albumin, acting as a local signal that activates repair and remodeling. The copper ion is essential — GHK without copper has much lower activity, and copper without the GHK carrier does not replicate its effects.
Downstream effects: The best-characterized downstream effects involve the extracellular matrix: GHK-Cu stimulates fibroblast activity, upregulates collagen and elastin synthesis, and promotes glycosaminoglycans such as hyaluronic acid and chondroitin sulfate. In wound models, it consistently accelerates healing, reduces scar formation versus controls, and promotes more organized tissue architecture — observed in skin, nerve, bone, and liver across independent groups.
Genomic signaling: Pickart's genomic studies identified GHK-Cu as capable of shifting the gene-expression signature of aged fibroblasts toward a younger phenotype — upregulating DNA-repair and mitochondrial genes while downregulating inflammation- and cancer-associated ones. If validated in human tissue at clinically relevant doses, these effects would be among the more compelling findings in aging biology.
What Does the Evidence Show?
The research evidence breaks down as follows.
Controlled studies: Multiple controlled studies have demonstrated GHK-Cu's ability to increase skin collagen density, reduce fine lines, and improve skin elasticity when applied topically. These findings are consistent across independent research groups and align with the compound's well-characterized mechanism. Topical GHK-Cu's safety profile is well-established, it has been in cosmetic use for decades with a strong record of tolerability.
Animal and in vitro: Animal and in vitro studies consistently show accelerated wound closure, improved tensile strength of healed tissue, and reduced scar formation with GHK-Cu treatment. The wound-healing evidence base is broader than for most peptides at this evidence tier, with studies across skin, nerve, bone, and gastrointestinal tissue from multiple independent research groups over several decades.
The broader claims: The more expansive claims around GHK-Cu, systemic longevity effects, broad gene expression reset, anti-cancer gene modulation, are primarily based on Pickart's genomic analyses using bioinformatics modeling of existing databases rather than direct experimental interventions. While mechanistically compelling, these claims have not been tested in prospective human clinical trials at systemically relevant doses.
Relevant Labs to Review
These biomarkers are most relevant to the tissue repair, inflammatory, and metabolic contexts in which GHK-Cu is studied.
Commonly Researched Alongside GHK-Cu
GHK-Cu is most often studied alongside other tissue repair and regeneration compounds, given its overlapping mechanisms in the extracellular matrix and fibroblast activation pathways.
Research Connections
Explore the Full Peptide Library
Browse research profiles for peptides across recovery, cognitive health, metabolic support, and longevity, all in one place.